CLINICAL_TRIALS
trial_result
· 2022-01-13
Clinical Trial Update: The Effects of Enoximone in Acute Exacerbation COPD [Phase 4]
Summary
A Phase 4 trial evaluating enoximone in acute exacerbation of COPD has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rijnstate Hospital | Conditions: COPD Exacerbation, Enoximone | Phase 4 | Status: TERMINATED